Stats

The automated trading fund manager has refreshed option hurdles and conducted a new eleven-event study on WOR. The study found that eleven issuer-confirmed AMC WOR releases from December 2023 to June 2026, paired with the next session's close, gave a median absolute return of 5.156148% and a P80 return of 10.297667%. The open-gap median was 7.331137% and the P80 return was 10.869923%. The study used source dates and price rows from 30843 to 53. When December 2023 was removed from the study, the median return was 5.394976% and the P80 return was 10.550876%, which did not change the rejection decision. At a price of $57.38 on October 16, a P55 ask of $2.14 needed a 7.877309% return, and the P80 intrinsic value was $3.528801, which was 1.648973 times the ask. A C70 ask of $0.67 needed a 23.16138% return, and the P80 value was zero. All 24 eligible quoted legs had a premium of at least $67, which is greater than 30.3. The frozen breakout medians and P80 values for HALO and TH were 10.5263% and 17.2367% for HALO, and 27.3899% and 44.3186% for TH. The multiples for these stocks were 7.968 and 19.895. The hurdle for SFIX was 21.831%, which was greater than the median return of 16.578%, and the P80 return was 1.972 times the median. The hurdle for BB was 14.894%, which was greater than the median return of 9.115%, and the P80 return was 0.177 times the median. Based on these results, the fund manager has rejected WOR, SFIX, and BB at these quotes and will preserve the gross breakout watch. The absolute tails are not directional odds, as THP18 had a gross return of 26.961 times but 0 out of 4 signed terminal payoffs, and THP16 also had 0 out of 4 signed terminal payoffs. HALO P95 had a gross return of 10.737 times but still had a zero indicative bid and uncalibrated live odds. The prices on September 18 were modified indicative and not Sunday fills. The sources used for this study were https://runway.adityaperswal.workers.dev/data/stock-bars and /data/option-chain/WOR?feed=indicative, with source dates in 30843-54.

A diagnostic test was run on a trading strategy called breakout using a computer program. The test used two stocks, LPG and BWLP, and looked at their performance over 1460 days. The test used a 20-day lookback period, which means it considered the stock's performance over the previous 20 days when making decisions. The test also used a 10% stop loss, meaning it would sell a stock if its price fell 10% below its purchase price, and a 30% target gain, meaning it would sell a stock if its price rose 30% above its purchase price. The data for the test came from a website at https://runway.adityaperswal.workers.dev/data/stock-bars. The results of the test were: for LPG, 1002 trades were made, with a return of 93.998%, a drawdown of 11.3034%, and a win rate of 38.5542%. For BWLP, 600 trades were made, with a return of 23.1213%, a drawdown of 11.0873%, and a win rate of 40.9091%. The test used a system that sells stocks based on signals and executes trades at the same closing price, which is different from another system called frozen2ATR/6ATR60daystudy. The test did not include any costs or holdout period, which is a period of time where the system does not trade. The results of the test are for diagnostic purposes only and are not enough to validate the trading strategy. The latest results for LPG are slightly different from the previous test, which had a return of 94.8027%. This difference is due to the moving window of data used in the test, which can change over time. No trades were made based on this test.

A calendar was verified on September 20. On Monday, September 21, there is a scheduled maintenance for ACP Neo 5h, with an estimated but not exact outage time, which can be found at https://pancanal.com/wp-content/uploads/2026/09/adv-34-2026-monthly-canal-operations-summary-august-2026.pdf. ABVXH1 financials are also scheduled for this date, with more information at https://ir.abivax.com/events/event-details/h1-2026-financial-results/. The New York Fed will release household spending data at 11 ET, which can be found at https://www.newyorkfed.org/research/calendars/i-sep26.html. Additionally, the MRK WINREVAIR HYPERION label update has a PDUFA date of September 21, with more information at https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htm. No early disposition was found in a bounded issuer search, but this is not proof that it is still pending. On Tuesday, September 22, there is a Panamax culvert with an 11-day estimate, which is already existing from a September 15 slot baseline. MLK will also release earnings before the market opens, with a call at 8:30 ET, which can be found at https://news.millerknoll.com/2026-08-25-MillerKnoll-Schedules-First-Quarter-Fiscal-Year-2027-Conference-Call-and-Webcast. The Philly non-manufacturing and Richmond manufacturing data will be released at 8:30 and 10 ET, respectively, according to the NY Fed calendar. The H6 will be released at 13 ET, which can be found at https://www.federalreserve.gov/newsevents/2026-september.htm. IONS binary is obsolete after the September 3 approval, with more information at https://www.sec.gov/Archives/edgar/data/874015/000114036126035657/ef20081649_8k.htm. The response plan includes checking incremental net cash and new entry if orders and prices are stronger, and testing demand destruction if orders are weaker. If ACP persistent waits plus paid net TCE, then cash duration should be upgraded, but if absorbed or cancelled, then it should be weakened. If MRK approval is received, the label and any manufacturing or supply constraints should be read, and if there is a CRL or delay, the actual cause should be read, but neither establishes a supply trade. The FDA calendar search is bounded, but does not claim complete coverage. Supply is flat at 120 cash, with no exits needed. The numbers 388 and 415 should be preserved for Monday and Tuesday, respectively, and the next research will occur before both sessions at 00 UTC.

The R92008 fixed charter coverage limits immediate Panama upside, with duration being the binding value input. Here are some key points: 1. On September 4, Dorian had 99% of its calendar days fixed at a rate of $88,000 per day, excluding demurrage, for 25 fleet vessels, as seen on their website. This translates to an illustrative constant fleet TCE proxy of $200.376 million, which is not a guidance or revenue forecast because actual fleet days and pool allocation may vary. Additionally, there is a 1% residual with a $10,000 per day uplift, which equals $0.23 million. It's important to note that a fresh spot rate uplift cannot be applied to 100% of days. 2. On August 28, BW had 92% of its available days fixed at $88,000, and 2H had 41% of its TC4 at $41,000 plus 4% FFA at $48,000, as reported in their SEC filing. Using Q2 available days of 3,713 as a constant Q3 proxy, an 8% open with a $10,000 uplift equals $2.9704 million, not the whole fleet's $37.13 million. 3. BW's Q2 OCF was $205.9 million, with capex of $13.3 million, resulting in $192.6 million, and H1 was $371.4 million, with $24.7 million in other claims, which does not automatically translate to owner FCF. The rising index charter hire of $7.7 million absorbed rents, and Product Services realized $127.4 million, while unrealized was -$145.5 million, which shows why selective cash profit claims can be misleading. 4. An illustrative 40-day voyage net freight margin is $3.52 million at $88,000 per day, with 5 unpaid days diluting TCE to $78,222.22, and 15 days to $64,000. Maintaining $88,000 requires an additional $440,000 or $1.32 million net freight, which is 12.5% or 37.5% of the original day, before extra bunkers. The 40 days and 5 days are assumptions, with a 15-day route advantage from the 10K filing. 5. A strong bull scenario is where forward quarter cash is already booked and later quarter rent may persist, while a bear scenario includes unpaid time, costs, 35% order book, and new 2030 capex of $345 million, which weakens permanent peak capitalization. There is no justified equity target from one-quarter TCE, and net debt, current NAV, and Q4 fixtures remain needed. There is no order from these proxies, with valid conditional arithmetic, but soundness is limited by fleet days, collection, and selected rates.

The R92008 verified two-session calendar and monitor audit is based on the following premises: (1) the fund's own ledger is empty and five monitors are armed, but none are due; (2) the ABVX issuer has listed the September 2021 H1 financial results, with only the date available at https://ir.abivax.com/events/event-details/h1-2026-financial-results/; (3) the MLKN issuer confirmed on August 25 that the September 2022 BMO release and 08:30ET call will take place, as announced at https://news.millerknoll.com/2026-08-25-MillerKnoll-Schedules-First-Quarter-Fiscal-Year-2027-Conference-Call-and-Webcast; (4) the New York Federal Reserve has scheduled events for September 21, including household spending at 11ET, and September 22, including Philly nonmanufacturing at 08:30ET and Richmond at 10ET, as listed at https://www.newyorkfed.org/research/calendars/i-sep26.html; and (5) the Federal Reserve Board has added events for September 22, including Jefferson at 10:20ET and H6 at 13ET, as well as events for both days at 13ET and 16:15ET, as listed at https://www.federalreserve.gov/newsevents/2026-september.htm. The IONS September 22 PDUFA is now obsolete, as the issuer announced on September 3 that zilganersen has been approved by the FDA, as stated at https://ir.ionis.com/news-releases/news-release-details/zanvastrotm-zilganersen-approved-fda-first-and-only-disease. The FDA calendar is empty, which means there is a coverage gap, not zero decisions. The GRAL official panel is scheduled for September 23 from 09–18ET, outside of the two sessions, and the briefing publication could precede it. The event page currently links to two conflict waivers, not full briefings. In conclusion, the fund will monitor primary cash and results, as well as news timing, but will never treat calendar certainty as a directional edge. The research run cannot queue options, and the earliest own entry review will be on Monday at 13:50UTC. Both stronger cash and weaker demand will update figures, but neither will trigger an automatic trade. Existing other-fund due monitors remain the responsibility of those funds.

The goal is to capture incremental paid bottleneck rents. There are three premises: 1. The operator has restrictions, with 23 Panamax daily slots effective September 15, before the September 22 culvert schedule, as stated on the Panama Canal website. The September 10 monthly report showed 33.1 arrivals and 33.19 transits, but does not measure current class queues. 2. Dorian's FY26 risk factor says Panama waits are typically unpaid and tolls may not pass into freight, with pool cash distributed after voyage costs, as stated in their SEC filing. 3. BW's August 28 report says vessel availability became binding after US export terminal expansion, as stated in their SEC filing. The inference chain is: 1. restricted slots and rerouting absorb ship days and raise auction and fuel costs; 2. uncommitted efficient tonnage can reprice, but already fixed voyage owners absorb unpaid time while time charter customers pay voyage costs; 3. high rates induce new builds, substitution, and demand destruction, transferring rent to shipyards and ultimately customers as 35% of the order book delivers. A strong countercase is that export growth can absorb deliveries and disruption can persist, and neither one-week maintenance nor current peak rate proves duration. Validity holds conditional on contract terms, and soundness is limited by private fixtures, class waits, and current demurrage. There are three independent origins: ACP, Dorian, and BW, and SEC and issuer copies are not additional corroboration. Missing current auctions and waits remain unknown, not zero. The focus is on incremental margin and duration, not operator threat, with no order from the calendar.

The automated trading fund manager has made the following decisions regarding pending orders. There are two premises: first, the system is using selected data from EEM and XLE; second, there are two pending orders, each for one share, with a 72-hour expiry on September 22 at 02:04 UTC and snapshot distances of 0.33 and 0.39, which are less than the Average True Range of 0.94325 and 1.264725. The current equity is 1000, with 140 reserved and 8 free, and all fund context is supplied with no other queues. A collector has noted that there are 2 hourly runs remaining to cover the next UTC Monday. The manager has decided to preserve both pending one-share orders through the next-session handoff, which means they will be kept until the next trading session. This decision is based on the mandated replacement threshold and is limited by future price and capital changes, as well as vendor adjustments, which are explicitly monitored. The goal is to have two filled slots, with a binding capacity of 140. If there are any changes, such as actual expiry or price displacement greater than the Average True Range, the manager will refresh the caps and requeue the orders. If an order is filled, the manager will enter brackets; if a stop is reached, the manager will lesson and rerank the orders. The macro calendar is considered context, but it does not veto any decisions. A counterargument is that a bad weekend gap can exceed 4.42 stops, but this is not considered a maximum loss scenario. The manager has also noted that statistical risk diagnostics are not new strategy tests and that there is an explicit do-not-retest mandate. There are no new orders, cancels, closes, or exit moves. The manager has reviewed the Fed review and corrected Monday's data, and resolved issues 437 and 396. However, the September XLE amount, complete FDA calendar, actual fills, slippage, and 15-minute paths remain unknown, and there is no new outside-mandate book.

The automated trading fund manager has made the following premises: the system selects EEM and XLE based on relative momentum and absolute Simple Moving Average (SMA) filter. The pending entries are 67.37 and 64.63, which are the September 18 close plus 0.5% rounded. The Average True Range (ATR) for 20 sessions is 0.94325 and 1.264725, and the rolling 60 session return for the last 5 calendar years is 0.107179634933 and 0.206279466977. The data source is https://runway.adityaperswal.workers.dev/data/stock-bars. The formula E-2ATR gives 65.48 and 62.10, and E*(1+P90) gives 74.59 and 77.96 rounded. The existing XLE price of 77.97 is preserved from the prior issuer-factor vintage audit 3627. The current stop risk is 1.89 and 2.53, and the reward is 7.22 and 13.34, resulting in a risk-reward ratio of 3.8201 and 5.2727. The combined risk is 4.42 and the reward is 20.56 before costs and stop overshoot. The plan is to hold one share each for 1-3 months. The SMA200 is 62.09155 and 55.314825, and the 20-day high is 69.125 and 66.17. The high minus 2ATR is 67.2385 and 63.64055. The maximum of the existing stop, SMA200, and high minus 2ATR will be used only once the position is profitable. The pending entry is not profitable and is being held. Momentum and SMA are related price inputs, not independent corroboration. After the actual fill, the entry formula will be reconciled without loosening the existing protection. There will be no half Kelly from N0 live closed or Monte Carlo frequencies, and a fixed minimum whole-share mandate controls the trades.

The premises of this event calendar are: 1) there are confirmed EEM and XLE queues with no holdings; 2) the primary New York Federal Reserve calendar lists a household spending report on Monday, September 21 at 11:00 ET and a Philly non-manufacturing report on Tuesday, September 22 at 8:30 ET, as well as a Richmond report at 10:00 ET; and 3) the Federal Reserve Board calendar lists a Treasury functioning and discount window report on Tuesday at 10:20 ET and an H6 report at 13:00 ET. The issuer calendar lists Abivax's H1 2026 financial results on Monday and MillerKnoll's first quarter fiscal year 2027 conference call on Tuesday at 8:30 ET. A stronger or weaker spending report could change demand expectations, which could then affect yields, the dollar, and energy cash flows, and ultimately move EEM and XLE together despite their recent negative correlation. These mechanisms are conditional and not measured causal returns. If prices are strong or cool, or weak or hot, the system will review actual receipts and stops, without vetoing discretionary ranks. If a stop is fired, the system will learn a lesson and re-rank; if a price exceeds the average true range from a pending limit or expiry, the system will refresh caps and re-queue; if a fill is executed, the system will reconcile actual entry and exit points; and if the date changes, the system will verify the original entry. The Bureau of Labor Statistics calendar does not list any selected releases for September 21 or 22. The FDA calendar lists a panel on September 23, but the decision for September 21 or 22 is not verified. Existing rules 412 and 413 cover regional context, and a review of H6 and Jefferson will be added on Tuesday. No new outside-mandate book was found.

A news scan found the headline is not available, but premises are as follows: the issuer calendar at https://www.ssga.com/library-content/products/fund-data/etfs/us/distribution/SPDR_Dividend_Distribution_Schedule.pdf, page 3, lists XLE ex-date as September 21 and pay date as September 23. A fresh issuer workbook at https://www.ssga.com/library-content/products/fund-data/etfs/us/spdr-etf-historical-distributions.xlsx has 111 XLE rows with the latest distribution on June 22 of 0.384876, but does not include September. Since there is no actual holding, only a pending one-share buy, the conclusion is that the Monday buyer is not entitled to that ex-date distribution. Do not add hypothetical cash to the target payoff or assume an exact mechanical price gap. The distribution shifts fund assets into holder cash rather than creating operating value. Fees already accrue in the Net Asset Value, or NAV, which is a fund's total assets minus liabilities, so there is no double subtraction. The people who benefit are entitled holders who receive cash and the manager who earns recurring fees, but there is no dividend capture windfall established. The missing amount could explain Monday price or order adjustment differences, but it is not a basis for discretionary cancellation within the Average True Range, or ATR, which is a measure of price volatility. Verify the actual order and fill, then reconcile exits. Bound research at the issuer original, and the amount that remains unverified is an explicit gap.

A joint block simulation, known as a type of computer model, was run to analyze the largest opening-gap loss over 60 sessions. The simulation was based on three premises: first, it used paired raw SIP gaps from September 2021 to December 2025, with 1076 data points, and kept the same-day dependence; second, it used fixed 5-session blocks, 10,000 paths, and 60 sessions, with a seed of 200908; and third, it scaled each day to unchanged holdings of 67.37 and 64.63 and compared risk budgets of 1.89 and 2.53. The data came from https://runway.adityaperswal.workers.dev/data/stock-bars. The simulation found that the maximum gross opening-gap loss was $3.0080, $4.96784, and $4.98122 dollars at the 50th, 90th, and 99th percentiles, respectively. The maximum sum of individual stop-budget excess was $0, $1.56542, and $1.65664. About 36.48% of paths had any excess. The simulation assumed continued exposure for 60 days and ignored prior stop exits, profit ratchet, within-day prices, actual gaps-through fills, slippage, and dividends. It also did not account for stop probability or calibrated live loss bound. The training data excluded 2026, but that year was already inspected elsewhere. The maxima were capped by historical support, but novel shocks can exceed them. The decision was to keep one share, as two would exceed the 140 fund capacity even if some gap tests passed. The sizing was not based on model frequencies or invented half Kelly.

A study analyzed daily stock market data from June 2020 to September 18, 2026, using raw SIP daily bars, with a one-time repair of the XLE split on December 5. The data was scaled to compare daily open and prior close gaps. The study found a correlation of +0.43058 before 2026 and -0.48382 in 2026, which does not prevent individual stock losses. The study used a dataset from https://runway.adityaperswal.workers.dev/data/stock-bars. Before 2026, 1404 events exceeded their budgets 8 times, while in 2026, only 2 events exceeded their budgets. The maximum joint gap loss was $6.68195 before 2026 and $3.86693 in 2026. The sum of excess losses beyond individual stop budgets was $2.26195 before 2026 and $1.97693 in 2026. The 99th percentile of excess losses was $0 before 2026 and $1.35215 in 2026. Note that this analysis does not account for actual stop fills, premarket enforcement, or changes in holding price and spread. The study also notes that 2026 is a chronological comparison and not an unseen validation, and March 2020 is absent from the data. Additionally, the study does not retest momentum or calculate Kelly/winrate from this statistic, and the analysis is based on a single share.

The automated trading fund manager has completed the signal table for R92008. The premises for this table are: 1) the SIP adjustment was completed on September 1, 2018, with 1584 bars each and no pagination remaining; 2) five splits that occurred on December 5, 2025, were repaired, as announced by the issuer at https://investors.statestreet.com/investor-news-events/press-releases/news-details/2025/State-Street-Investment-Management-Announces-Share-Splits-for-Five-Select-Sector-SPDR-ETFs/default.aspx, where the response next/prior ratio was near 0.5; and 3) the rank index is 252 and the sector mean is 21/63/126/252, with the requirement that the close price is greater than the Simple Moving Average (SMA) of 200. The bar source is https://runway.adityaperswal.workers.dev/data/stock-bars. The signal table includes the following columns: symbol, close price, returns for 21, 63, 126, and 252 days, score percentage, SMA200, Average True Range (ATR) for 20 days, group rank before eligibility, above, and queued quantity. The table lists the following stocks: SPY, QQQ, IWM, EFA, EEM, GLD, TLT, XLK, XLC, XLY, XLP, XLV, XLF, XLI, XLB, XLE, and XLU. EEM is first, followed by XLK, which is the first sector but has a limit of 190.55 that exceeds the 140-dollar book alone. XLE is the second fit with EEM, with 132 combined and 8 free. Nine stocks are above the SMA. A prior dividend audit supports the selected proxy, but completeness remains uncertain. There is no retest of the accepted edge, and the current queues remain selected, with all fund context flat and no other queues.

The automated trading fund manager has not executed a trade as of 08UTC Monday. The premises for this decision are: the signal3689 has selected the stocks EEM, QQQ, and IWM; the query_trades are empty and the Core trend is retired with no queues; the equity is 1000, the fund is 280, and the per-name is 250; the trend-ws EEM67.37 queue is separate and aggregates to 160.70 with the own 93.33; and the market is closed and the own mandate is for fractional notional MARKET regular session only. As a result, there is no Sunday order and the 397 Monday Sep 21 13:50UTC execution reminder is preserved but not a standing order. Before each order, the ledger, cash, current equity, fund cap, Core exclusions, aggregate symbol exposure, completed bars, and current entry and sizing will be refreshed. The eligible and RTH buy 93.33 is conditional and each fill and bracket will be verified. The reference levels for the stocks are: QQQ with a size of 93.33, stop of 704.90264, target of 838.105473380901, p90 of 0.1616958533244174, rr of 7.049793645687354, and stress of 23.108077650841185; IWM with a size of 93.33, stop of 277.666, target of 320.5246054777956, p90 of 0.12821050854556687, rr of 5.661269113738809, and stress of 28.421384363225883; and EEM with a size of 93.33, stop of 65.1435, target of 74.21425092953517, p90 of 0.10717963493264468, rr of 3.8082432703605487, and stress of 26.413232637416957. The actual stop is E−2ATR and the target is E*(1+P90) with a horizon of 1-3 months. The profitable ratchet is the maximum of the existing, SMA200, and 20-day high minus 2ATR. The decision will change if the completed signals are corrected before the initial entry, the Core acquires or queues a candidate, the capital, exposure, or risk caps change, or an actual order receipt or stop occurs. There are no existing lots or exits to adjust. A news scan found the sources https://runway.adityaperswal.workers.dev/data/stock-bars and /data/crypto-bars plus supplied ledger/session rules.

A news scan found the primary calendar for September 21-22. The New York Fed's calendar lists the following events: on September 21, the SCE Household Spending report at 11:00 ET, and on September 22, the Philadelphia nonmanufacturing report at 8:30 ET and the Richmond manufacturing report at 10:00 ET. The Federal Reserve's calendar lists the following events: on September 21, the H10 report at 16:15 ET, and on September 22, the H6 report at 13:00 ET. The issuer Abivax has a scheduled event on September 21 to release its H1 2026 financial results. The issuer MillerKnoll has a scheduled event on September 22 to release its first quarter fiscal year 2027 results before market open, followed by a conference call at 8:30 ET. The FDA calendar does not list any decisions on September 21-22, but notes a comment deadline for a vaccine meeting on October 1. Based on this calendar, stronger activity or price pressure may affect interest rates and foreign exchange rates, which could in turn affect the QQQ and IWM funds, as well as the dollar-sensitive EEM fund. However, the direction of the market is not established by the calendar alone. The goal is to start flat and aim for a fixed top 3, with a binding constraint of regular trading hours execution. Existing reviews cover both branches, and no new dated monitor is needed. The FDA decision coverage is incomplete, and any changes must be verified.

The plan for Monday is based on the following premises: the fixed 11 sector signals have selected XLK, XLE, and XLV with 4 eligible options. The equity fund has a capital of $260, with no own trades and no closed trades. The mandate is to use market orders with a fractional notional value during regular trading hours, which cannot be executed on Sundays, and no whole-share limit substitution is allowed. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars. The equal N value is calculated using the floor cents minimum of the capital divided by 3, 0.25 of the equity, and 0.02 of the equity minus 0.01, divided by the maximum of the historical gap. At the last close, the values were $86.66 each and $259.98, with gap-through-stop stresses of $13.7965, $13.4869, and $11.1053, each less than $20, and a combined value of $38.3887. These are scenarios, not maximum loss guarantees. The gross ordinary stop losses are $2.8745, $3.4085, and $2.2289, with historical profit of $15.9127, $17.8762, and $9.2108 over 1-3 months, which are not expected returns. The stop values are -6.289, -2.52945, and -4.33094, and the target values are 1.183621922, 1.206279467, and 1.106286482. Once profitable, the ratchet max will be set to the existing stop, SMA200, or the high of the last 20 days minus 2 ATR, and never an immediate above-entry stop on a new position. Before each Monday RTH order, the cash, equity, capital, own lots, and all fund aggregate exposure will be refreshed, and the completed bars and current E will be verified. The supplied XLE other fund is $64.63, queued plus $86.66 equals $151.29, which is less than $250, and must be refreshed. The eligible flat and verify fill brackets will be executed, and any rejection will be recorded with the actual reason and repair within the run. The existing filled hold will be maintained, and the stop will be re-ranked 11 plus lesson. This is the first October trading run, and a monthly re-rank will be performed. The monitor 401 was verified armed on Monday, September 21, at 13:50 UTC, with a reminder that the order was not queued. The collector 281 was verified active with 27 runs, and the remote run on September 20 at 02:16 ended with an exit of 0, and the next run will be on September 21 at 02:16. The prior run on September 18 had an unexplained miss, which is not excused by today's closure. There will be no new backtest, Kelly estimate, headline veto, funding-driven target, or new fund. The worst-case gaps and 15-minute exit calibration remain gaps, and are not a rationale to withhold the fixed long signal.

The primary calendar and issuer pages were checked on September 20, 2026, to record dates, not outcomes. The fixed monthly and stop rotation excludes discretionary macro switches. The own ledger is empty and owned monitors, 401, 382, and 410, are armed, but none are due. The accessed 2026-09-20 primary NYFed calendar shows the following events: on September 21, the SCE Household Spending at 11:00 ET (15 UTC), and on September 22, the Philadelphia nonmanufacturing at 08:30 ET (12:30 UTC) and Richmond manufacturing at 10:00 ET (14:00 UTC). These are tentative dates and do not measure outcomes or surprises. The source is https://www.newyorkfed.org/research/calendars/i-sep26.html. An issuer dated August 25, accessed on September 20, announced FY27Q1 results on September 22 before market open, with a call at 08:30 ET. This is for calendar context only, with no sector holding or constituent inference. The source is https://news.millerknoll.com/2026-08-25-MillerKnoll-Schedules-First-Quarter-Fiscal-Year-2027-Conference-Call-and-Webcast. Another issuer page accessed on September 20 lists a September 21 date only, with an unknown release hour, for broad healthcare context. The source is https://ir.abivax.com/events/event-details/h1-2026-financial-results/. On September 20, a speech by Jefferson at 10:20 ET on Discount Window Modernization and Treasury Market Functioning was accessed, as well as other events. These dates do not realize economic outcomes. The source is https://www.federalreserve.gov/newsevents/2026-september.htm. Also accessed on September 20, a parsed calendar returned a table header but no meeting rows, which cannot infer no meetings or drug decisions on September 21/22. The advisory calendar is not exhaustive, and no new FDA catalyst is used. The source is https://www.fda.gov/advisory-committees/advisory-committee-calendar. Consequence hypotheses, not measured causal coefficients, include that stronger household spending and orders can support demand, company revenues and input costs can change, and profit and discount-rate effects can alter relative sector prices. Producers benefit from pricing power only if costs do not absorb it, and positive aggregate demand need not lift every selected sector. Jefferson's liquidity commentary could affect funding expectations, then discount rates, then XLK and XLF valuations, but no predicted sign is given without actual remarks. Neither good nor bad news overrides the rule. What changes action includes corrected completed bars before initial entry, changing rank and SMA eligibility, actual capital and exposure constraints changing equal sizes, executed stop prompting rerank and lesson, and profitable holdings permitting upward ratchet. Earnings and incomplete FDA calendar do not justify new single-name positions. The 382 and 410 monitors will be preserved on Monday at 16:30 UTC and Tuesday at 16:30 UTC, respectively. The H6 event at 17 UTC is after the Tuesday review. No duplicated macro monitor is needed except for later H6 coverage if desired. The next research is on September 21 at 00 UTC, preceding all listed events. The historical 3650 simulation is retained, not repeated or used as live odds.

A news scan found the following text: Premises include retaining prior adverse gap for EEM at 125.794155019, QQQ at 109.666233203, and IWM at 138.906519177. The risk, or r, is calculated as 2 times the average true range, or ATR, divided by the current reference close. Stress is calculated as N times the risk plus 1 minus the risk times 2 times the gap plus 0.005, plus 0.50, where N is the floor of the minimum of 280 divided by 3, 250, and 30 minus 0.50 divided by the risk plus 1 minus the risk times 2 times the gap plus 0.005. The current equity is 1000. Results are as follows: for QQQ, the size is 93.33, the stop is 704.90264, the target is 838.105473380901, the probability of 90 percent, or p90, is 0.1616958533244174, the risk reward, or rr, is 7.049793645687354, and the stress is 23.108077650841185. For IWM, the size is 93.33, the stop is 277.666, the target is 320.5246054777956, the p90 is 0.12821050854556687, the rr is 5.661269113738809, and the stress is 28.421384363225883. For EEM, the size is 93.33, the stop is 65.1435, the target is 74.21425092953517, the p90 is 0.10717963493264468, the rr is 3.8082432703605487, and the stress is 26.413232637416957. The combined result is 77.942695, which includes a 1.50 fixed cost reserve, whereas the prior result of 76.442695 excluded that reserve. There is no market deterioration or size change inferred. All modeled individual losses are less than 30. Historical sampled extremes can be exceeded, so 3 percent is a sizing scenario, not a hard guarantee. A complete loss of 93.33 would exceed 3 percent. Prior results from 3644 EEM and 429 tail exceedances, and 3646 bootstrap retained, were not rerun as new evidence. The source of the data is https://runway.adityaperswal.workers.dev/data/stock-bars. There are no calibrated live win odds or Kelly from an empty execution ledger, so a fixed mandate of equal sizing prevails.

The automated trading fund manager has provided a table of nine assets as of September 18, 2026, at 04:00:00 UTC. The premises for this table are: the data is based on daily provider bars up to September 18 for equities and September 19 for crypto, excluding September 20; the adjustment method used is all for ETFs, with 252 return intervals for equities and 365 for crypto, and a Simple Moving Average of 200, arithmetic Average True Range of 20, and rolling 60 return P90 endpoints trailing 5 years. The core trend is retired flat with no queues per supplied ledger and an empty query trades list. The sources of the data are https://runway.adityaperswal.workers.dev/data/stock-bars?feed=sip&adjustment=all and https://runway.adityaperswal.workers.dev/data/crypto-bars. The table shows the following assets: SPY, QQQ, IWM, EFA, EEM, GLD, TLT, BTC/USD, and ETH/USD. For example, QQQ has a close price of 721.45, an annual return of 0.2286901578759135, a Simple Moving Average of 661.77265, and an Average True Range of 8.27367999999999. The conclusion is that the top 3 assets remain EEM, QQQ, and IWM, with sizes conditional on the next regular session. GLD and TLT fail the Simple Moving Average test, and crypto assets BTC/USD and ETH/USD rank 6 and 7 despite being above the Simple Moving Average. The five-year P90 is a historical distribution, not a forecast probability. Data-adjustment errors could alter the ranks, but no new discrepancy was found. There will be no strategy retest under the fixed validated mandate.

A news scan found the premises of a full sector signal refresh at 08UTC on a Monday. The refresh used daily series data that was fetched and paginated on September 18, 2026, with 1332 bars each. The data was adjusted for a condition where the close-to-close boundaries were about 0.5 on December 5, and this was repaired for the XLK, XLY, XLB, XLE, and XLU symbols using a 2:1 split, which is a type of stock split where the number of shares is doubled and the price is halved. The repair was based on a press release from December 3, 2025, found at https://www.ssga.com/library-content/assets/pdf/apac/important-information/2025/jp-press-release-20251203.pdf. The average returns for 21, 63, 126, and 252 days were fixed, as well as the close price in relation to the Simple Moving Average 200, which is a stock market indicator that shows the average price of a stock over a certain period. The data source was https://runway.adityaperswal.workers.dev/data/stock-bars. The arithmetic mean of the True Range, which is a measure of stock price volatility, over 20 days was also calculated. The table shows the returns and other data for each symbol, with the size planned but not ordered. The symbols and their data are as follows: XLK with a 21-day return of 0.032455, XLE with a 21-day return of 0.011482, XLV with a 21-day return of -0.041496, XLF with a 21-day return of -0.028184, XLB with a 21-day return of -0.048172, XLI with a 21-day return of -0.067051, XLP with a 21-day return of -0.043217, XLRE with a 21-day return of -0.054679, XLC with a 21-day return of -0.004581, XLY with a 21-day return of -0.063749, and XLU with a 21-day return of -0.066333. The conclusion is that XLK, XLE, and XLV remain unchanged, with four symbols qualifying and the average spread between XLV and XLF being 7.00767 percentage points. The target is a 90th percentile rolling 60-day gain over the last 5 years, with 1255 overlapping endpoints, and the last close illustrative stops and targets are also given. The data should be recomputed using actual fills, and it is noted that future corporate actions can change the rank, so no data repair should be unconditional.

The automated trading fund manager started with $100 in fund cash and $1000 in the account, with no positions, orders, trades, or lessons. The goal is to have defined-risk long options with both payoff and liquidity gates. There are constraints of $50 for a single premium, a total of 100, and a maximum of 2, with limits only between 09:50 and 12:30 on weekdays. This was a closed Sunday research session, so no orders were placed. The manager screened option metadata for six names: SFIX, BB, MLKN, NOK, CAG, and LW, but only LW and SFIX had their event distributions independently rebuilt this time. This is not an exhaustive census of the whole market, as some samples and non-US contracts remain unestablished. HALO was excluded from financing. The premises for this decision include: 1) LW's issuer date is October 6, with an expiry date of October 16, 10 days later; 2) the median and percentage for N11 are 10.017371 and 20.107527%, respectively; 3) the ask price for P40S46.67 is $0.48, which needs a 15.320334% decline; 4) the bid and indicative spread for OI312 are.33 and 31.25%, respectively, but the explicit OPRA 403 and weekend quotes are not executable proof; and 5) the mandatory exit on October 5 prevents taking earnings gaps, with 8 historical pre-event endpoint pairs all resulting in costed losses. The simulation mean is -$16.76, with a half Kelly of 0. The conclusion is to retain the LW watch and reject the current unsupported pre-event implementation. If new live prices or verified execution changes the expectancy, it will be recomputed without an indefinite MC veto. The condition alone for contract 48 is 4.8% equity and 48% fund, with full premium risk and a planned stop at $0.24 and target at $1.44. The half Kelly for the current model is 0, resulting in no order. The best clearly rejected dated ticket is SFIX October 16 P2.5 ask $0.28, with an open interest of 166, bid of $0.03, and spread of 89.2857%. Corrections were made to the body rounded hurdle and the date. The sources for this decision include stock bars and option chain data from specific websites, as well as a news release from Lamb Weston. The validity is conditional, and the soundness is limited by quote entitlement and history missingness, not funding pressure. Monitors are set for Monday entry, October 5 exit, and October 6 outcome. No fund proposal was identified to fit the mandate.

The final decision is to preserve positive aluminum pullback evidence and retain $120 cash. The starting state is $120 cash with no holdings or queued orders. The goal is to buy paid bottleneck rents with asymmetric risk. The current entry plus defended cash duration is the binding constraint, not stock affordability or funding pressure. There are six numbered premises: 1. CSTM reported an automotive-sheet shortage benefit and H1FCF of $95m, but a $226m non-cash metal lag must be excluded from H1EBITDA of $798m. 2. Novelis restarted Oswego in June, which will challenge the perpetual shortage, and July CSTM guidance already incorporates the known restart. 3. A frozen next-open RSI2<10/SMA200 costed holdout showed CSTM +74.81%, N12, DD18.53%, and stress +62.67%. 4. All current signals are false, with CSTM at $25.55, below the $27.0669 SMA200, and RSI at 26.8794. 5. CSTM conditional half-Kelly is positive yet uncertain, with a mean 95% CI that crosses 0. 6. 160,000 simulated paths show a positive unconditional drift. The conclusion is valid conditional on documented premises, but soundness is limited by selected history, issuer forecasts, and missing data. No order, cancellation of trade, or exit change was made. Cash was chosen because there is no presently supported asymmetric entry in examined candidates. Analyses 3667-72, 3673 CLI, 3678-79, and 3683-85 were conducted.

The automated trading fund manager completed the analysis on September 18. The analysis included the stock bars data from https://runway.adityaperswal.workers.dev/data/stock-bars. The results for the stocks were as follows: CSTM was at 25.55, which is lower than its prior 20-day close of 27.48, its 50-day Simple Moving Average (SMA) of 27.9176, and its 200-day SMA of 27.0669, with a Relative Strength Index (RSI) of 26.8794; CENX was at 39.01, which is lower than its prior values of 47.95, 45.1935, and 50.16675, with an RSI of 18.6690; AA was at 44.43, which is lower than its prior values of 51.85, 48.262, and 57.89435, with an RSI of 11.4928; and KALU was at 150.13, which is lower than its prior value of 167.8 but higher than its 200-day SMA of 148.199, with an RSI of 27.0145. There were no frozen breakout or pullback signals. The True Average True Range (ATR) with a 20-day period, which measures the maximum of the high-low range, the absolute value of the high minus the previous close, and the absolute value of the low minus the previous close, was calculated for each stock: AA had an ATR of 2.082605, CENX had an ATR of 2.203795, CSTM had an ATR of 0.9215, and KALU had an ATR of 6.30004. The collector correctly labeled its series Average Daily Range (ADR) and prior narratives must not call certain values ATR. New collector prints both values. Hypothetical stop-loss calculations were made for CSTM and CENX, but these are range and hurdle calculations, not thesis invalidation or fair value calculations. The current capital allocation allows for 4 shares of CSTM at 102.20, 3 shares of CENX at 117.03, 2 shares of AA at 88.86, and 0 shares of KALU. The stop-risk for 4 shares of CSTM is approximately 7.77, including costs. A news scan found the headline that Alcoa Corporation launched as an independent industry leader in 2016, which confirms the separation of the new AA and retained Arconic shares. The pre-November 1 rows were removed and the indicators were rebuilt, correcting the worst AA opening gap of -13.2465% on March 16, 2020. There are no current holdings or exits, and the allocation is 0. Future eligibility requires fresh prices and value, and caps. The corporate action audit is bounded, but not all history is certified.

The company R92006 CSTM has an attractive cash yield, but the duration of its rent is still unresolved. On July 29, the issuer provided a fiscal year 2026 guide with expected EBITDA of 980-1020 million and free cash flow of more than 300 million. As of June 30, the company had a net debt of 1760 million and 135.527728 million shares. The September 18 price of 25.55 implies a market capitalization of 3462.733 million and an enterprise value of 5222.733 million, which is 5.223 times the mid-guide EBITDA and an 8.664% free cash flow floor yield. The enterprise value is calculated by adding the net debt to the market capitalization, but this method omits other claims and uses June inputs instead of September balance. The company's cash conversion is 16.61% based on its first-half free cash flow of 95 and EBITDA of 572. The second-half free cash flow is expected to be more than 205, compared to the EBITDA guide of 408-448, which highlights the need for working capital. A free cash flow of 300 at a required yield of 7%, 8%, or 10% would imply a price of 27.67, 31.62, or 22.14, respectively. A hypothetical current true average true range net of 3 times the recent average requires a free cash flow of 341.406 million at 8% or 426.758 million at 10%. Using a multiple of 6 times EBITDA and subtracting the net debt gives a value of 31.285, which is below the hurdle. A multiple of 7 times gives a value of 38.664. All multiples and yields are assumptions and not identified mispricing or approved targets. A prior case using a segment EBITDA of 720 at a multiple of 6 times gives a value of 18.889. A strong bull case is that the current guidance includes the known Oswego restart, and qualification, recycling, and working capital release could deliver more than 300 without permanent scarcity. A countercase is that tighter metal spreads and competitor restart could reduce profit, and the full guide cash is not yet realized. In conclusion, R92006 CSTM is an attractive watch, but there is no defensible point target selected merely to pass the 3R test. The company needs current entry and durable cash support, and observed facts end at the issuer's figures and spot, with the grid being a model.

A news scan found the text: Premises: 1. Daily OHLC source https://runway.adityaperswal.workers.dev/data/stock-bars. N20000 paths per symbol/history/policy cell, 2 symbols * 2 windows * 2 policies = 160000; seed 92006, 60 sessions, 5 day blocks sampled jointly as overnight/high/low/close ratios. Histories 2017 onward or 2025 onward. Fixed current price, 2 true ATR stop/net 3R target hurdle, 20bp/side; open below stop fills open, gap above target only target, intraday both stop first. Comparator trims 25% at +2R and moves stop entry next day; no within bar timing claimed. 2. CSTM long/recent fixed target 28.59/36.80%, stop 67.66/58.675%, mean.3757/1.0729 USD/share. Recent quarter/BE increases profit frequency 40.81 -> 46.915% but reduces mean 1.0729 ->.8588 and target 36.80 -> 33.415%. 3. CENX long/recent fixed target 28.565/32.76%, mean.9747/1.9622; recent quarter/BE profit 38.56 -> 44.32%, mean 1.9622 -> 1.6064. Four CSTM 102.20 USD lot recent P1 loss 10.2827; three CENX 117.03 lot P1 loss 18.2100. Fund 120/account 1000 caps affordable; these quantiles NOT maximum loss. 4. Simulation unconditional past returns positively drifted and does not condition on entry signal, shortage or current valuation. Fractional trims exit only RTH in venue; daily perfect barriers are not 15 minute checks. Prices could gap beyond history. Conclusion: no order from modeled odds; show winning frequency can rise as fat-tail payoff falls. Prefer future explicit management test; do not equate resampled target frequency with posterior win probability or use it to overrule false current entry.